Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Beltran

Showing results (391-400 of 406) with videos related to

Pageof 41
Sort By:
Anesthesia and Analgesia|October 23, 2018
Perioperative Management and In-Hospital Outcomes After Minimally Invasive Repair of Pectus Excavatum: A Multicenter Registry Report From the Society for Pediatric Anesthesia Improvement NetworkWallis T Muhly, Ralph J Beltran, Alan Bielsky, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
Dual inhibition of GTP-bound (ON) and GDP-bound (OFF) KRAS <sup>G12C</sup> suppresses PI3Kα and leads to potent tumor inhibitionKatherine Parker, Samar Ghorbanpoor, Wafa Malik, et al.
International Journal of Particle Therapy|October 23, 2020
The Importance of Verification CT-QA Scans in Patients Treated with IMPT for Head and Neck CancersJaden D Evans, Riley H Harper, Molly Petersen, et al.
Frontiers in Oncology|April 24, 2023
Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planningJ John Lucido, Todd A DeWees, Todd R Leavitt, et al.
Nature Medicine|February 6, 2024
Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial resultsSergio Crespo-Garcia, Frédérik Fournier, Roberto Diaz-Marin, et al.
Cell Metabolism|February 6, 2021
Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL inhibitionSergio Crespo-Garcia, Pamela R Tsuruda, Agnieszka Dejda, et al.
Journal of Medicinal Chemistry|May 14, 2015
Discovery of N-(4-(3-(2-aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), a highly selective, orally bioavailable inhibitor of aurora kinases with activity against multidrug-resistant cancer cell linesStephanie Geuns-Meyer, Victor J Cee, Holly L Deak, et al.
Nature Cancer|December 27, 2023
Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancersMarc Payton, Brian Belmontes, Kelly Hanestad, et al.
Annals of the American Thoracic Society|September 29, 2023
Diversity, Equity, and Inclusion in the Pediatric Pulmonary Workforce: An Official American Thoracic Society Workshop ReportNicole Stephenson, Erick Forno, Theresa A Laguna, et al.
Cancer Discovery|March 6, 2026
Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic MutantsCarlos Stahlhut, Anna E Maciag, Kyle A Sullivan, et al.
Pageof 41

Showing results (391-400 of 406) with videos related to

Sort By:
Pageof 41
Anesthesia and Analgesia|October 23, 2018
Perioperative Management and In-Hospital Outcomes After Minimally Invasive Repair of Pectus Excavatum: A Multicenter Registry Report From the Society for Pediatric Anesthesia Improvement NetworkWallis T Muhly, Ralph J Beltran, Alan Bielsky, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
Dual inhibition of GTP-bound (ON) and GDP-bound (OFF) KRAS <sup>G12C</sup> suppresses PI3Kα and leads to potent tumor inhibitionKatherine Parker, Samar Ghorbanpoor, Wafa Malik, et al.
International Journal of Particle Therapy|October 23, 2020
The Importance of Verification CT-QA Scans in Patients Treated with IMPT for Head and Neck CancersJaden D Evans, Riley H Harper, Molly Petersen, et al.
Frontiers in Oncology|April 24, 2023
Validation of clinical acceptability of deep-learning-based automated segmentation of organs-at-risk for head-and-neck radiotherapy treatment planningJ John Lucido, Todd A DeWees, Todd R Leavitt, et al.
Nature Medicine|February 6, 2024
Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial resultsSergio Crespo-Garcia, Frédérik Fournier, Roberto Diaz-Marin, et al.
Cell Metabolism|February 6, 2021
Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL inhibitionSergio Crespo-Garcia, Pamela R Tsuruda, Agnieszka Dejda, et al.
Journal of Medicinal Chemistry|May 14, 2015
Discovery of N-(4-(3-(2-aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), a highly selective, orally bioavailable inhibitor of aurora kinases with activity against multidrug-resistant cancer cell linesStephanie Geuns-Meyer, Victor J Cee, Holly L Deak, et al.
Nature Cancer|December 27, 2023
Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancersMarc Payton, Brian Belmontes, Kelly Hanestad, et al.
Annals of the American Thoracic Society|September 29, 2023
Diversity, Equity, and Inclusion in the Pediatric Pulmonary Workforce: An Official American Thoracic Society Workshop ReportNicole Stephenson, Erick Forno, Theresa A Laguna, et al.
Cancer Discovery|March 6, 2026
Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic MutantsCarlos Stahlhut, Anna E Maciag, Kyle A Sullivan, et al.
Pageof 41